Tomoverse Imaging Information

Tomoverse Imaging Inc. is a Montréal-based medical software company building a Patient Intelligence Platform for structural heart care. The platform follows each patient from intake through imaging review, Heart Team decision, procedure and follow-up, giving clinical teams one continuously updated record that serves the clinic, the registry and the clinical trial without duplicate data entry. At its core is tvCT, a cardiac CT planning and visualization engine designed by interventional cardiologists for transcatheter aortic, mitral and tricuspid procedures. Tomoverse was founded on a simple observation: for many patients, waiting for a structural heart procedure carries more risk than the procedure itself. Our mission is that no patient's wait should be deadlier than their procedure. By combining advanced computational and cloud technologies with deep clinical expertise, we give heart teams a clear view of where every patient stands, the means to act before delay becomes dangerous, and a way to measure the result in days from referral to treatment. Tomoverse collaborates with leading Canadian heart centres and structural heart device companies. tvCT is in development toward regulatory clearance. Founded by leaders in cardiology and medtech innovation, Tomoverse Imaging is committed to delivering intuitive, reliable, and high-performance software solutions that enhance clinical outcomes and streamline procedural workflows.